Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1989-06-30
1992-08-25
Cashion, Jr., Merrell C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 20, 530324, 530325, 930170, 930DIG821, 930DIG820, 930DIG800, A61K 3702, C07K 710
Patent
active
051419246
ABSTRACT:
Vasoactive intestinal peptide analogs containing substitutions of appropriately selected amino acids at specific positions of the VIP molecule.
REFERENCES:
patent: 4605641 (1986-08-01), Bolin et al.
patent: 4734400 (1988-03-01), Bolin et al.
patent: 4737487 (1988-04-01), Watts et al.
patent: 4822774 (1989-04-01), Ito et al.
patent: 4835252 (1989-05-01), Musso et al.
Biochemical & Biophysical Research Comm. vol. 121, No. 2, 1984, pp. 493-498.
Peptides, Chemistry & Biology, Marshall, pp. 440-443, 1988.
Schaaper et al., Chem. Abs. vol. 100, No. 19, 156971m, (1984) [Recl., J.R. Neth. Chem. Soc. 103(1) pp. 17-22].
Musso et al., Biochemistry, vol. 27, pp. 8174-8181, (1988).
Barnes, Pharmac. Ther., vol. 36, pp.119-129 (1988).
Pandol et al., "VIP Receptor Antagonist", Rapid Communication, G553-G557, (1986).
Tachibana et al., Peptide Chemistry, pp. 481-486, (1987).
Cashion Jr. Merrell C.
Epstein William H.
Gould George M.
Hoffmann-La Roche Inc.
Pokras Bruce A.
LandOfFree
Synthetic vasoactive intestinal peptide analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic vasoactive intestinal peptide analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic vasoactive intestinal peptide analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-385066